Top Markets
#1 DogBull DogBull +36.28%
#2 The Bitcoin Bull The Bitcoin Bull +30.25%
#3 Siacoin Siacoin +27.47%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Pons Pons +20.43%
#6 MarsCoin MarsCoin +18.55%
#7 Ontology Gas Ontology Gas +18.26%
#8 Cash Cat Cash Cat +17.41%
#9 Akedo Akedo +12.86%
#10 Cryptopia Cryptopia +11.07%
Coin of the day
DogBull DogBull
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
Rangering i aksjer #14759
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Aksjekurs
$2.35
Markedsverdi
$394.12M
Endring (1 dag)
-1.07%
Endring (1 år)
-64.75%
Land
TW
Handel Lumosa Therapeutics Co., Ltd. (6535)

Kategori

Healthcare
Inntekter for Lumosa Therapeutics Co., Ltd. (6535)
Inntekter i 2026 TTM: 0
Ifølge Lumosa Therapeutics Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Lumosa Therapeutics Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH